Literature DB >> 25261427

Exon 3 splicing and mutagenesis identify residues influencing cell surface density of heterologously expressed silkworm (Bombyx mori) glutamate-gated chloride channels.

Shogo Furutani1, Makoto Ihara1, Yuri Nishino1, Miki Akamatsu1, Andrew K Jones1, David B Sattelle1, Kazuhiko Matsuda2.   

Abstract

Glutamate-gated chloride channels (GluCls) mediate fast inhibitory neurotransmission in invertebrate nervous systems. Insect GluCls show alternative splicing, and, to determine its impact on channel function and pharmacology, we isolated GluCl cDNAs from larvae of the silkworm (Bombyx mori). We show that six B. mori glutamate-gated chloride channel variants are generated by splicing in exons 3 and 9 and that exons 3b and 3c are common in the brain and third thoracic ganglion. When expressed in Xenopus laevis oocytes, the three functional exon 3 variants (3a, b, c) all had similar EC50 values for l-glutamate and ivermectin (IVM); however, Imax (the maximum l-glutamate- and IVM-induced response of the channels at saturating concentrations) differed strikingly between variants, with the 3c variant showing the largest l-glutamate- and IVM-induced responses. By contrast, a partial deletion detected in exon 9 had a much smaller impact on l-glutamate and IVM actions. Binding assays using [(3)H]IVM indicate that diversity in IVM responses among the GluCl variants is mainly due to the impact on channel assembly, altering receptor cell surface numbers. GluCl variants expressed in HEK293 cells show that structural differences influenced Bmax but not Kd values of [(3)H]IVM. Domain swapping and site-directed mutagenesis identified four amino acids in exon 3c as hot spots determining the highest amplitude of the l-glutamate and IVM responses. Modeling the GluCl 3a and 3c variants suggested that three of the four amino acids contribute to intersubunit contacts, whereas the other interacts with the TM2-TM3 linker, influencing the receptor response.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261427     DOI: 10.1124/mol.114.095869

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae.

Authors:  Jacob I Meyers; Meg Gray; Wojtek Kuklinski; Lucas B Johnson; Christopher D Snow; William C Black; Kathryn M Partin; Brian D Foy
Journal:  J Exp Biol       Date:  2015-05-15       Impact factor: 3.312

2.  Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin.

Authors:  Nurit Degani-Katzav; Revital Gortler; Marina Weissman; Yoav Paas
Journal:  Front Mol Neurosci       Date:  2017-04-06       Impact factor: 5.639

3.  Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization.

Authors:  Nurit Degani-Katzav; Moshe Klein; Moran Har-Even; Revital Gortler; Ruthi Tobi; Yoav Paas
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

4.  The fungal alkaloid Okaramine-B activates an L-glutamate-gated chloride channel from Ixodes scapularis, a tick vector of Lyme disease.

Authors:  Shogo Furutani; Makoto Ihara; Kristin Lees; Steven D Buckingham; Frederick A Partridge; Jonathan A David; Rohit Patel; Scott Warchal; Ian R Mellor; Kazuhiko Matsuda; David B Sattelle
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-06-04       Impact factor: 4.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.